Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Characterization of IL-18 expression and release in the pathogenesis of chronic rhinosinusitis.

Okano M, Fujiwara T, Makihara S, Fujiwara R, Higaki T, Kariya S, Noda Y, Haruna T, Nishizaki K.

Int Arch Allergy Immunol. 2013;160(3):275-86. doi: 10.1159/000341668. Epub 2012 Oct 17.

PMID:
23075512
2.

IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis.

Shin HW, Kim DK, Park MH, Eun KM, Lee M, So D, Kong IG, Mo JH, Yang MS, Jin HR, Park JW, Kim DW.

J Allergy Clin Immunol. 2015 Jun;135(6):1476-85.e7. doi: 10.1016/j.jaci.2015.01.003. Epub 2015 Feb 25.

PMID:
25725991
3.

COX/PGE(2) axis critically regulates effects of LPS on eosinophilia-associated cytokine production in nasal polyps.

Higaki T, Okano M, Fujiwara T, Makihara S, Kariya S, Noda Y, Haruna T, Nishizaki K.

Clin Exp Allergy. 2012 Aug;42(8):1217-26. doi: 10.1111/j.1365-2222.2012.04015.x.

4.

Regulatory effect of TLR3 signaling on staphylococcal enterotoxin-induced IL-5, IL-13, IL-17A and IFN-γ production in chronic rhinosinusitis with nasal polyps.

Okano M, Fujiwara T, Kariya S, Higaki T, Makihara S, Haruna T, Noyama Y, Koyama T, Omichi R, Orita Y, Miki K, Kanai K, Nishizaki K.

Allergol Int. 2016 Jan;65(1):96-102. doi: 10.1016/j.alit.2015.08.005. Epub 2015 Oct 6.

5.

Staphylococcal protein A-formulated immune complexes suppress enterotoxin-induced cellular responses in nasal polyps.

Okano M, Fujiwara T, Kariya S, Haruna T, Higaki T, Noyama Y, Makihara S, Kanai K, Nishizaki K.

J Allergy Clin Immunol. 2015 Aug;136(2):343-50.e8. doi: 10.1016/j.jaci.2014.10.058. Epub 2015 Feb 25.

PMID:
25724120
6.

Role of fungal antigens in eosinophilia-associated cellular responses in nasal polyps: a comparison with enterotoxin.

Okano M, Fujiwara T, Haruna T, Kariya S, Makihara S, Higaki T, Nishizaki K.

Clin Exp Allergy. 2011 Feb;41(2):171-8. doi: 10.1111/j.1365-2222.2010.03584.x. Epub 2010 Oct 7.

PMID:
21039976
7.

Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4.

Soyka MB, Wawrzyniak P, Eiwegger T, Holzmann D, Treis A, Wanke K, Kast JI, Akdis CA.

J Allergy Clin Immunol. 2012 Nov;130(5):1087-1096.e10. doi: 10.1016/j.jaci.2012.05.052. Epub 2012 Jul 26.

PMID:
22840853
8.

Nasal biomarker profiles in acute and chronic rhinosinusitis.

Riechelmann H, Deutschle T, Rozsasi A, Keck T, Polzehl D, Bürner H.

Clin Exp Allergy. 2005 Sep;35(9):1186-91.

PMID:
16164446
9.

Cellular responses to Staphylococcus aureus alpha-toxin in chronic rhinosinusitis with nasal polyps.

Okano M, Fujiwara T, Kariya S, Higaki T, Haruna T, Matsushita O, Noda Y, Makihara S, Kanai K, Noyama Y, Taniguchi M, Nishizaki K.

Allergol Int. 2014 Dec;63(4):563-73. doi: 10.2332/allergolint.14-OA-0703. Epub 2014 Jul 25.

10.

Staphylococcal enterotoxin B induced expression of IL-17A in nasal epithelial cells and its association with pathogenesis of nasal polyposis.

Jin J, Yoon YH, Kwak SY, Rha KS, Kim YM.

Eur Arch Otorhinolaryngol. 2014 Mar;271(3):525-34. doi: 10.1007/s00405-013-2589-7. Epub 2013 Jun 14.

PMID:
23765061
11.

The antimicrobial protein short palate, lung, and nasal epithelium clone 1 (SPLUNC1) is differentially modulated in eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps.

Wei Y, Xia W, Ye X, Fan Y, Shi J, Wen W, Yang P, Li H; Nasal Health Group, China (NHGC).

J Allergy Clin Immunol. 2014 Feb;133(2):420-8. doi: 10.1016/j.jaci.2013.09.052. Epub 2013 Dec 15.

PMID:
24342548
12.

Regulation and expression of IL-32 in chronic rhinosinusitis.

Soyka MB, Treis A, Eiwegger T, Menz G, Zhang S, Holzmann D, Akdis CA, Meyer N.

Allergy. 2012 Jun;67(6):790-8. doi: 10.1111/j.1398-9995.2012.02820.x. Epub 2012 Apr 9.

13.

Increased expression of IL-19 in the epithelium of patients with chronic rhinosinusitis and nasal polyps.

Pace E, Scafidi V, Di Bona D, Siena L, Chiappara G, Ferraro M, La Grutta S, Gallina S, Speciale R, Ballacchino A, Bachert C, Bousquet J, Gjomarkaj M.

Allergy. 2012 Jul;67(7):878-86. doi: 10.1111/j.1398-9995.2012.02842.x. Epub 2012 May 14.

14.

Prostaglandin E(2) suppresses staphylococcal enterotoxin-induced eosinophilia-associated cellular responses dominantly through an E-prostanoid 2-mediated pathway in nasal polyps.

Okano M, Fujiwara T, Haruna T, Kariya S, Makihara S, Higaki T, Nishizaki K.

J Allergy Clin Immunol. 2009 Apr;123(4):868-74.e13. doi: 10.1016/j.jaci.2009.01.047. Epub 2009 Feb 28.

PMID:
19254809
15.

IL-22/IL-22R1 signaling regulates the pathophysiology of chronic rhinosinusitis with nasal polyps via alteration of MUC1 expression.

Noyama Y, Okano M, Fujiwara T, Kariya S, Higaki T, Haruna T, Makihara SI, Kanai K, Koyama T, Taniguchi M, Ishitoya JI, Kanda A, Kobayashi Y, Asako M, Tomoda K, Nishizaki K.

Allergol Int. 2017 Jan;66(1):42-51. doi: 10.1016/j.alit.2016.04.017. Epub 2016 Aug 5.

16.

Chronic rhinosinusitis with nasal polyps and without nasal polyps is associated with increased expression of lysophosphatidic acid-related molecules.

Park SJ, Jun YJ, Lee KJ, Hwang SM, Kim TH, Lee SH, Lee SH.

Am J Rhinol Allergy. 2014 May-Jun;28(3):199-207. doi: 10.2500/ajra.2014.28.4032.

PMID:
24980231
17.

Differential expression of interleukin-32 in chronic rhinosinusitis with and without nasal polyps.

Keswani A, Chustz RT, Suh L, Carter R, Peters AT, Tan BK, Chandra R, Kim SH, Azam T, Dinarello CA, Kern RC, Schleimer RP, Kato A.

Allergy. 2012 Jan;67(1):25-32. doi: 10.1111/j.1398-9995.2011.02706.x. Epub 2011 Sep 7.

18.

The characterization of IL-17A expression in patients with chronic rhinosinusitis with nasal polyps.

Jiang XD, Li GY, Li L, Dong Z, Zhu DD.

Am J Rhinol Allergy. 2011 Sep-Oct;25(5):e171-5. doi: 10.2500/ajra.2011.25.3645.

PMID:
22186234
19.

Staphylococcus aureus enterotoxin B contributes to induction of nasal polypoid lesions in an allergic rhinosinusitis murine model.

Kim DW, Khalmuratova R, Hur DG, Jeon SY, Kim SW, Shin HW, Lee CH, Rhee CS.

Am J Rhinol Allergy. 2011 Nov-Dec;25(6):e255-61. doi: 10.2500/ajra.2011.25.3727.

PMID:
22185735
20.

PAR-2 activation regulates IL-8 and GRO-alpha synthesis by NF-kappaB, but not RANTES, IL-6, eotaxin or TARC expression in nasal epithelium.

Rudack C, Steinhoff M, Mooren F, Buddenkotte J, Becker K, von Eiff C, Sachse F.

Clin Exp Allergy. 2007 Jul;37(7):1009-22.

PMID:
17581194

Supplemental Content

Support Center